A Study to Investigate Different Doses of 0382 in Overweight and Obese Subjects With Type 2 Diabetes Mellitus.
Status:
Completed
Trial end date:
2018-01-23
Target enrollment:
Participant gender:
Summary
A Phase 2 study with two cohorts of differing doses designed to evaluate the efficacy, safety
and pharmacokinetics (PK) of MEDI0382 in patients with Type 2 Diabetes Mellitus (T2DM).
Approximately 63 subjects will be enrolled across two cohorts.